Biosensor Technology involves the development and application of devices that detect and quantify biological molecules by converting biological responses into measurable signals. These devices, known as biosensors, play a critical role in diverse fields, including healthcare, environmental monitoring, and food safety. Biosensors typically consist of a biological component, such as enzymes, antibodies, or nucleic acids, integrated with a transducer that converts the biological response into an electrical, optical, or other measurable signal. The interaction between the biological element and the target analyte provides a specific and sensitive detection mechanism. In healthcare, biosensor technology is widely employed for diagnostics, monitoring glucose levels, detecting biomarkers indicative of various diseases, and facilitating point-of-care testing. In environmental applications, biosensors contribute to the rapid detection of pollutants, toxins, and pathogens. Advancements in nanotechnology and materials science have led to the development of miniaturized and wearable biosensors, enhancing their portability and real-time monitoring capabilities. Continuous glucose monitoring for diabetes management and wearable fitness trackers are examples of biosensor applications in everyday life. Challenges in biosensor technology include optimizing sensitivity, selectivity, and stability, as well as addressing issues related to reproducibility and cost-effectiveness. Ongoing research focuses on improving sensor performance, exploring new biomaterials, and expanding the range of analytes that can be detected, thereby extending the impact of biosensor technology in various fields.
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Stem cell technologies to integrate biodesign related tissue engineering within the frame of cell based regenerative medicine: towards the preventive therapeutic and rehabilitative resources and benefits
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : In vitro evaluation of lyophilized Dedifferentiated Fat cells (DFAT) impregnated artificial dermis
Kazutaka Soejima, Nihon University, School of Medicine, Japan
Title :
Nagy Habib, Imperial College London, United Kingdom
Title :
Alexander Seifalian, Nanotechnology & Regenerative Medicine Commercialisation Centre, United Kingdom
Title : The regenerative medicine of the future
Marco Polettini, DVM, Italy